InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Tovey Christopher J., Chief Executive Officer. Officer active across 2 companies, notably GW Pharmaceuticals PLC. Cumulatively, 6 disclosures have been published. The latest transaction was disclosed on 5 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€159,3291,096 shares@ €145.37360.0011% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-22-000043:0·
07,820 shares0
Ordinary Shares
SEC:0001765581-22-000032:0·
2,496 shares
Ordinary Shares
SEC:0000899243-21-018673·
09,091 shares0
Ordinary Shares
SEC:0001765581-21-000057·
2,496 shares
Ordinary Shares
SEC:0000899243-21-018673:0·
09,091 shares0
Ordinary Shares
SEC:0001765581-21-000057:0·
6 of 6 declarations
About Tovey Christopher J.
Christopher J. Tovey is the Chief Operating Officer and Executive Vice President at GW Pharmaceuticals PLC and Jazz Pharmaceuticals plc. In this role, he oversees the daily operations of the company and contributes to the overall strategy. His expertise in the pharmaceutical industry is an asset to both firms.
